These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 2212948)

  • 1. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis.
    Ruddle NH; Bergman CM; McGrath KM; Lingenheld EG; Grunnet ML; Padula SJ; Clark RB
    J Exp Med; 1990 Oct; 172(4):1193-200. PubMed ID: 2212948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical role for lymphotoxin in experimental allergic encephalomyelitis.
    Suen WE; Bergman CM; Hjelmström P; Ruddle NH
    J Exp Med; 1997 Oct; 186(8):1233-40. PubMed ID: 9334362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta 1 inhibits tumor necrosis factor-alpha/lymphotoxin production and adoptive transfer of disease by effector cells of autoimmune encephalomyelitis.
    Stevens DB; Gould KE; Swanborg RH
    J Neuroimmunol; 1994 Apr; 51(1):77-83. PubMed ID: 7512580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis.
    Frei K; Eugster HP; Bopst M; Constantinescu CS; Lavi E; Fontana A
    J Exp Med; 1997 Jun; 185(12):2177-82. PubMed ID: 9182689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity.
    Powell MB; Mitchell D; Lederman J; Buckmeier J; Zamvil SS; Graham M; Ruddle NH; Steinman L
    Int Immunol; 1990; 2(6):539-44. PubMed ID: 1707660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination.
    Selmaj K; Raine CS; Cross AH
    Ann Neurol; 1991 Nov; 30(5):694-700. PubMed ID: 1722388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for surface lymphotoxin in experimental autoimmune encephalomyelitis independent of LIGHT.
    Gommerman JL; Giza K; Perper S; Sizing I; Ngam-Ek A; Nickerson-Nutter C; Browning JL
    J Clin Invest; 2003 Sep; 112(5):755-67. PubMed ID: 12952924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that Fas and FasL contribute to the pathogenesis of experimental autoimmune encephalomyelitis.
    Dittel BN
    Arch Immunol Ther Exp (Warsz); 2000; 48(5):381-8. PubMed ID: 11140465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, mice.
    Sean Riminton D; Körner H; Strickland DH; Lemckert FA; Pollard JD; Sedgwick JD
    J Exp Med; 1998 May; 187(9):1517-28. PubMed ID: 9565643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local delivery of TNF by retrovirus-transduced T lymphocytes exacerbates experimental autoimmune encephalomyelitis.
    Dal Canto RA; Shaw MK; Nolan GP; Steinman L; Fathman CG
    Clin Immunol; 1999 Jan; 90(1):10-4. PubMed ID: 9884347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
    Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
    Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice.
    Mackay F; Majeau GR; Lawton P; Hochman PS; Browning JL
    Eur J Immunol; 1997 Aug; 27(8):2033-42. PubMed ID: 9295042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes.
    Browning JL; Sizing ID; Lawton P; Bourdon PR; Rennert PD; Majeau GR; Ambrose CM; Hession C; Miatkowski K; Griffiths DA; Ngam-ek A; Meier W; Benjamin CD; Hochman PS
    J Immunol; 1997 Oct; 159(7):3288-98. PubMed ID: 9317127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of relapsing autoimmune encephalomyelitis with T cell receptor V beta-specific antibodies when proteolipid protein is the autoantigen.
    Whitham RH; Wingett D; Wineman J; Mass M; Wegmann K; Vandenbark A; Offner H
    J Neurosci Res; 1996 Jul; 45(2):104-16. PubMed ID: 8843028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adoptively transferred experimental autoimmune encephalomyelitis in SJL/J, PL/J, and (SJL/J x PL/J)F1 mice. Influence of I-A haplotype on encephalitogenic epitope of myelin basic protein.
    McCarron R; McFarlin DE
    J Immunol; 1988 Aug; 141(4):1143-9. PubMed ID: 3260919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes. TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma.
    Andrews JS; Berger AE; Ware CF
    J Immunol; 1990 Apr; 144(7):2582-91. PubMed ID: 1969453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin beta receptor-Ig fusion protein.
    Columba-Cabezas S; Griguoli M; Rosicarelli B; Magliozzi R; Ria F; Serafini B; Aloisi F
    J Neuroimmunol; 2006 Oct; 179(1-2):76-86. PubMed ID: 16870269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour necrosis factor and lymphotoxin: molecular aspects and role in tissue-specific autoimmunity.
    Körner H; Sedgwick JD
    Immunol Cell Biol; 1996 Oct; 74(5):465-72. PubMed ID: 8912010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12.
    Leonard JP; Waldburger KE; Goldman SJ
    J Exp Med; 1995 Jan; 181(1):381-6. PubMed ID: 7528773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system.
    Körner H; Lemckert FA; Chaudhri G; Etteldorf S; Sedgwick JD
    Eur J Immunol; 1997 Aug; 27(8):1973-81. PubMed ID: 9295034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.